Saudi Chemical Co plans to manufacture drug for thrombosis

Subsidiary AJA Pharmaceutical Industries will explore manufacturing pre-filled syringes for treatment of thrombosis, which affects COVID-19 patients who have severe symptoms of the virus

  
Medicine in shelves in commissioning machine in pharmacy. Image used for illustrative purpose

Medicine in shelves in commissioning machine in pharmacy. Image used for illustrative purpose

Getty Images

Saudi Chemical Company Holding (SCCH) is planning to manufacture Clexane, a drug used in the treatment of thrombosis, which impacts a high percentage of COVID-19 patients with severe symptoms.

SCCH subsidiary AJA Pharmaceutical Industries Ltd (AJA Pharma) signed a memorandum of understanding to consider making the Sanofi pre-filled syringes in Saudi Arabia.

The Jeddah-based company said in a statement to the Saudi Stock Exchange (Tadawul) that it would provide manufacturing facilities and systems to produce the drug and extend Clexane services into the Saudi market.

The MOU has been signed for an 18-month period.

(Reporting by Imogen Lillywhite; editing by Seban Scaria)

Disclaimer: This article is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Read our full disclaimer policy here.

© ZAWYA 2021


More From Health